Atria Wealth Solutions’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $857K | Sell |
12,419
-24,067
| -66% | -$1.66M | 0.02% | 703 |
|
|
2025
Q1 | $2.57M | Sell |
36,486
-5,851
| -14% | -$412K | 0.03% | 544 |
|
|
2024
Q4 | $3.64M | Buy |
42,337
+2,315
| +6% | +$199K | 0.04% | 441 |
|
|
2024
Q3 | $4.77M | Sell |
40,022
-5,109
| -11% | -$608K | 0.05% | 363 |
|
|
2024
Q2 | $6.44M | Buy |
45,131
+5,463
| +14% | +$780K | 0.07% | 281 |
|
|
2024
Q1 | $5.11M | Buy |
39,668
+2,619
| +7% | +$337K | 0.06% | 332 |
|
|
2023
Q4 | $3.83M | Buy |
37,049
+8,266
| +29% | +$855K | 0.05% | 377 |
|
|
2023
Q3 | $2.62M | Buy |
28,783
+5,275
| +22% | +$480K | 0.04% | 476 |
|
|
2023
Q2 | $1.9M | Buy |
23,508
+5,542
| +31% | +$448K | 0.03% | 580 |
|
|
2023
Q1 | $1.44M | Sell |
17,966
-2,458
| -12% | -$197K | 0.02% | 665 |
|
|
2022
Q4 | $1.38M | Buy |
20,424
+7,836
| +62% | +$530K | 0.02% | 631 |
|
|
2022
Q3 | $627K | Buy |
12,588
+8,488
| +207% | +$423K | 0.01% | 908 |
|
|
2022
Q2 | $228K | Sell |
4,100
-1,976
| -33% | -$110K | ﹤0.01% | 1345 |
|
|
2022
Q1 | $340K | Buy |
+6,076
| New | +$340K | 0.01% | 1256 |
|